Law360, New York ( November 10, 2014, 10:20 AM EST) -- On Nov. 5, 2014, the District of Delaware denied a motion to dismiss for lack of personal jurisdiction that had been filed by a defendant in a Hatch-Waxman case. See generally AstraZeneca AB v. Mylan Pharmaceuticals Inc., Civ. No. 1:14 cv-00696, Doc. 26 (D. Del. Nov. 5, 2014) ("Slip. Op."). In the accompanying decision, Judge Gregory M. Sleet held that Delaware could exercise specific jurisdiction over the defendant abbreviated new drug application filer. Importantly, this decision is the first opinion by a district court to address personal jurisdiction in the Hatch-Waxman context following the U.S. Supreme Court's landmark decision in Daimler AG v. Bauman, 134 S. Ct. 746 (2014)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.